NCT00925574View on ClinicalTrials.gov

A Study of the Safety and How the Body Affects a Drug (CNTO 1959) in Healthy Volunteers and in Patients With Psoriasis

PHASE1CompletedINTERVENTIONAL
Enrollment

71

Participants

Timeline

Start Date

June 4, 2009

Primary Completion Date

October 11, 2010

Study Completion Date

October 11, 2010

Conditions
Psoriasis
Interventions
DRUG

CNTO 1959; Placebo

Trial Locations (8)

Unknown

Los Angeles

San Diego

Miramar

Overland Park

Baltimore

St Louis

New York

Portland

Sponsors

Lead Sponsor

Centocor, Inc.
All Listed Sponsors
lead

Centocor, Inc.

INDUSTRY

NCT00925574 - A Study of the Safety and How the Body Affects a Drug (CNTO 1959) in Healthy Volunteers and in Patients With Psoriasis | Biotech Hunter | Biotech Hunter